Results 121 to 130 of about 1,296,216 (290)

Targeting the EpCAM‐AXL axis to overcome drug resistance in lung cancer

open access: yesMolecular Oncology, EarlyView.
Lung cancer cells often evade therapy by hijacking signaling pathways. We reveal that cleaved EpCAM (sEpCAM) stabilizes the oncogenic protein AXL, driving NF‐κB and STAT3‐mediated chemoresistance. This EpCAM‐AXL axis identifies a high‐risk patient subset with poor prognosis.
Alexa Guerrero‐Alba   +5 more
wiley   +1 more source

Characterization of therapeutic antibodies targeting lymphatic and vascular resistance factor for the treatment of hypervascularized and highly metastatic cancers

open access: yesMolecular Oncology, EarlyView.
LVRF (lymphatic and vascular resistance factor) is a VEGFA splice variant upregulated in response to anti‐angiogenic therapy that fosters tumor adaptation through enhanced vascularization, lymphangiogenesis, and metastatic dissemination. Targeting LVRF with fully human neutralizing antibodies disrupts these processes and limits resistant tumor growth ...
Marion David   +12 more
wiley   +1 more source

Linear Interference Suppression With Covariance Mismatches in MIMO-OFDM Systems

open access: yes, 2014
International audienceInterference cancellation is a key design concern for next-generation communication systems. One practical approach is the interference rejection combining (IRC) scheme, which is already being considered as the base receiver for ...
Sari, Hikmet   +3 more
core   +1 more source

Interference suppression techniques for OPM-based MEG: Opportunities and challenges. [PDF]

open access: yesNeuroimage, 2022
Seymour RA   +6 more
europepmc   +1 more source

Interference suppression in digital holographic images

open access: yesКомпьютерная оптика
This paper presents a digital filtering software module for noise suppression in reconstructed holographic images and in original digital holograms.
N.N. Yudin   +7 more
doaj   +1 more source

Overcoming platinum resistance by the disulfiram metabolite CuET in novel preclinical models of human carcinomas

open access: yesMolecular Oncology, EarlyView.
Cisplatin‐resistant cancer cells survive DNA‐damaging platinum‐based treatment yet remain sensitive to CuET‐induced proteotoxic stress. The distinct mechanism of action allows CuET to overcome and eliminate cisplatin‐resistant tumour cells, unless highly expressed metallothioneins (MTs) interfere with CuET, thereby highlighting MT levels as candidate ...
Stefanos Arampatzis   +20 more
wiley   +1 more source

Performance Analysis of RFID Interference Suppression System Based on the Gold Code

open access: yes, 2022
Performance Analysis of RFID Interference Suppression System Based on the Gold ...
Suk-Seung Hwang (13431909)   +1 more
core  

Home - About - Disclaimer - Privacy